Metastatic NSCLCs With Limited Tissues: How to Effectively Identify Driver Alterations to Guide Targeted Therapy in Chinese Patients

INTRODUCTION: Molecular diagnostics of newly diagnosed patients with metastatic NSCLC (mNSCLC) with limited tissue samples often face several obstacles in routine practice using next-generation sequencing (NGS), mainly owing to insufficient tissue or DNA; thus, how to effectively identify the molecu...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Weihua, Li, Yan, Guo, Lei, Liu, Yutao, Yang, Lin, Ying, Jianming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474491/
https://www.ncbi.nlm.nih.gov/pubmed/34590019
http://dx.doi.org/10.1016/j.jtocrr.2021.100167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474491/
https://www.ncbi.nlm.nih.gov/pubmed/34590019
http://dx.doi.org/10.1016/j.jtocrr.2021.100167

Ejemplares similares